None
Quote | Kazia Therapeutics Limited (NASDAQ:KZIA)
Last: | $0.39 |
---|---|
Change Percent: | 0.26% |
Open: | $0.388 |
Close: | $0.389 |
High: | $0.4019 |
Low: | $0.3801 |
Volume: | 39,021 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Kazia Therapeutics Limited (NASDAQ:KZIA)
2024-04-05 10:30:00 ET April 5, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies offer therapies for cancer, eye di...
Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases PR Newswire SYDNEY , March 21, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is ...
Message Board Posts | Kazia Therapeutics Limited (NASDAQ:KZIA)
Subject | By | Source | When |
---|---|---|---|
Another one,Mr big shot, average price $1.05 sold | trendzone | investorshub | 11/01/2022 2:55:46 PM |
u sound angry....nice pick...lol | TrendTrade2016 | investorshub | 11/01/2022 2:22:28 PM |
What they really need to do is get | trendzone | investorshub | 10/27/2022 5:03:10 PM |
I'm in let. Goo positive | Pt3 | investorshub | 10/27/2022 12:25:24 PM |
KAZIA'S PAXALISIB DEMONSTRATES POSITIVE MONOTHERAPY EFFICACY SIGNALS IN | crudeoil24 | investorshub | 10/27/2022 12:19:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Kazia Therapeutics Limited Company Name:
KZIA Stock Symbol:
NASDAQ Market:
Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $...
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-q...
2024-04-05 10:30:00 ET April 5, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies offer therapies for cancer, eye di...